Y-Intercept (HK)’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $387K | Sell |
21,727
-1,765
| -8% | -$31.4K | 0.01% | 1285 |
|
|
2025
Q1 | $419K | Buy |
23,492
+4,723
| +25% | +$84.2K | 0.03% | 778 |
|
|
2024
Q4 | $559K | Buy |
+18,769
| New | +$559K | 0.04% | 676 |
|
|
2024
Q2 | – | Sell |
-123,939
| Closed | -$1.94M | – | 1757 |
|
|
2024
Q1 | $1.94M | Buy |
123,939
+56,302
| +83% | +$880K | 0.15% | 175 |
|
|
2023
Q4 | $1.01M | Buy |
67,637
+17,254
| +34% | +$258K | 0.09% | 317 |
|
|
2023
Q3 | $814K | Buy |
+50,383
| New | +$814K | 0.08% | 380 |
|
|
2022
Q1 | – | Sell |
-5,248
| Closed | -$394K | – | 880 |
|
|
2021
Q4 | $394K | Sell |
5,248
-775
| -13% | -$58.2K | 0.09% | 316 |
|
|
2021
Q3 | $700K | Buy |
+6,023
| New | +$700K | 0.13% | 249 |
|
|
2021
Q2 | – | Sell |
-6,239
| Closed | -$781K | – | 810 |
|
|
2021
Q1 | $781K | Buy |
+6,239
| New | +$781K | 0.21% | 148 |
|